Literature DB >> 19301173

A review of German Scedosporium prolificans cases from 1993 to 2007.

K Tintelnot1, G Just-Nübling, R Horré, B Graf, I Sobottka, M Seibold, A Haas, U Kaben, G S De Hoog.   

Abstract

Scedosporium prolificans is one of the most life-threatening fungal opportunistic pathogens due to its high resistance to common systemic antifungal agents. While a close relative of Pseudallescheria boydii, S. prolificans has a more limited geographic range being primarily found in Australia, USA and Spain. Infections have also been reported from several other European countries and from Chile. Twenty patients with Scedosporium prolificans infection or colonization from August 1993 to May 2007 were retrospectively reviewed in Germany. They had all been identified at or reported to the Reference Laboratory for Pseudallescheria/Scedosporium spp. in Berlin. Twelve of 13 patients with haematological disorders and/or on immunosuppressive therapy developed a fatal invasive scedosporiosis. Colonization of the respiratory tract was reported for one patient after heart-lung-transplantation, all six patients with cystic fibrosis and one with chronic sinusitis. Molecular studies of the S. prolificans isolates confirmed that parts of the 18S, the Internal Transcribed Spacer (ITS) regions and the D1/D2 domain of the 28S region of rDNA are monomorphic. However, sequencing of parts of the translation elongation factor EF1-alpha (EF-1alpha) and the chitin synthase (CHS-1) genes revealed the presence of three and two distinct genotypes, respectively. Two informative mutations were found in EF-1alpha and a single nucleotide exchange in the CHS-1 gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301173     DOI: 10.1080/13693780802627440

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  18 in total

Review 1.  Mucormycosis, pseudallescheriasis, and other uncommon mold infections.

Authors:  Clifford Quan; Brad Spellberg
Journal:  Proc Am Thorac Soc       Date:  2010-05

Review 2.  [Differential diagnosis for detection of hyphae in tissue].

Authors:  K Tintelnot
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

3.  Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.

Authors:  Yotaro Ochi; Nobuhiro Hiramoto; Hiroshi Takegawa; Noboru Yonetani; Asako Doi; Chihiro Ichikawa; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

4.  Rapid identification of Pseudallescheria and Scedosporium strains by using rolling circle amplification.

Authors:  Michaela Lackner; Mohammad Javad Najafzadeh; Jiufeng Sun; Qiaoyun Lu; G Sybren de Hoog
Journal:  Appl Environ Microbiol       Date:  2011-11-04       Impact factor: 4.792

5.  Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.

Authors:  Qiaoyun Lu; Yi Sun; Dingdan Tian; Shoubao Xiang; Lujuan Gao
Journal:  Mycopathologia       Date:  2017-08-23       Impact factor: 2.574

6.  Identification of Pseudallescheria and Scedosporium species by three molecular methods.

Authors:  Qiaoyun Lu; A H G Gerrits van den Ende; J M J E Bakkers; Jiufeng Sun; M Lackner; M J Najafzadeh; W J G Melchers; Ruoyu Li; G S de Hoog
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

7.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

8.  Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.

Authors:  Natasha E Holmes; Janine M Trevillyan; Sarah E Kidd; Trishe Y-M Leong
Journal:  Med Mycol Case Rep       Date:  2013-04-19

Review 9.  Impact of multidrug-resistant organisms on patients considered for lung transplantation.

Authors:  Shmuel Shoham; Pali D Shah
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

Review 10.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.